Inhibition of human allergic T-cell responses by IL-10–treated dendritic cells: Differences from hydrocortisone-treated dendritic cells
- 31 August 2001
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 108 (2), 242-249
- https://doi.org/10.1067/mai.2001.117177
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Immunobiology of Dendritic CellsAnnual Review of Immunology, 2000
- Reciprocal Control of T Helper Cell and Dendritic Cell DifferentiationScience, 1999
- Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditionsEuropean Journal of Immunology, 1997
- IL-10: a potential therapy for allergic inflammation?Immunology Today, 1997
- Effect of interleukin‐10 on dendritic cell maturation and functionEuropean Journal of Immunology, 1997
- Functional diversity of helper T lymphocytesNature, 1996
- Interleukin‐12 Production by Dendritic CellsAnnals of the New York Academy of Sciences, 1996
- Activation of human dendritic cells through CD40 cross-linking.The Journal of Experimental Medicine, 1994
- Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytesEuropean Journal of Immunology, 1994
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991